shortagewatch

Home / Nervous system / Chlordiazepoxide

ATC N05BA02 · Benzodiazepine Derivatives

Chlordiazepoxide shortage

As of 2 Nov 2026, Chlordiazepoxide has a reported shortage in 3 of the 16 countries we track (Canada, Czechia, Japan), covering 6 products from 3 companies.

Countries3/16
Products6packs or presentations
Companies30 listed
Short since15 Aug 20233.2 years ago
Earliest return1 Jan 2027company estimate
Main reasonManufacturing problem

Timeline

CanadaCzechiaJapan
202420252026CHLORDIAZEPOXIDE (100 BTL)CHLORDIAZEPOXIDE (100 BTL)CHLORDIAZEPOXIDE (100 BTL)CHLORDIAZEPOXIDE (100 BTL)ELENIUM 10MG 10MG TBL OBD 20ELENIUM 10MG 10MG TBL OBD 20クロルジアゼポキシド散1%「ツルハラ」クロルジアゼポキシド散1%「ツルハラ」クロルジアゼポキシド錠10mg「ツルハラ」クロルジアゼポキシド錠10mg「ツルハラ」クロルジアゼポキシド錠5mg「ツルハラ」クロルジアゼポキシド錠5mg「ツルハラ」today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Tsuruhara3AA Pharma2Tarchomi Skie1

Compared with similar medicines

ATC group N05BA · Benzodiazepine Derivatives
Diazepam7/16Alprazolam6/16Lorazepam5/16Bromazepam4/16Chlordiazepoxide3/16Oxazepam2/16Potassium Clorazepate2/16Prazepam2/16Clobazam1/16Etizolam1/16Ketazolam1/16

Affected products

CountryProductCompanySinceExpected backReason
CACHLORDIAZEPOXIDE (100 BTL)AA PHARMA INC15 Aug 2023not givenManufacturing problem
Disruption of the manufacture of the drug
CACHLORDIAZEPOXIDE (100 BTL)AA PHARMA INC15 Aug 2023not givenManufacturing problem
Disruption of the manufacture of the drug
CZELENIUM 10MG 10MG TBL OBD 20Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A., Varšava13 Aug 20261 Jan 2027Manufacturing problem
Výrobní důvody
クロルジアゼポキシド散1%「ツルハラ」鶴原製薬4 Aug 2026not givenActive ingredient shortage
Raw material (active ingredient) supply problem
クロルジアゼポキシド錠10mg「ツルハラ」鶴原製薬4 Aug 2026not givenActive ingredient shortage
Raw material (active ingredient) supply problem
クロルジアゼポキシド錠5mg「ツルハラ」鶴原製薬4 Aug 2026not givenActive ingredient shortage
Raw material (active ingredient) supply problem

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.